Peter B. Bach, MD
peterbachmd
Intriguing @theNCI @NCIDrDougLowy @NEJM study showing lung cancer mortality rates falling since 2013 faster than incidence rates. Study title claims they observed the impact of improved treatments. I think that
Read more
Our paper (ty @medrxivpreprint): Remdesivir @GileadSciences pricing justification & plausibility of Rem reducing hosp length of stay by 4 days (LOS). While ACTT-1 study showed 4 day faster recovery for
Read more
Remdesivir priced at $3,120 for 5 day course (10 day also in EUA and twice as much). $GILD says will discount to $2,340 for ‘government programs (incl Medicare)’ in the
Read more
In @TheLancet - study today compares outcomes for Covid patients who got usual care or chloroquine/hydroxychloroquine with or without a macrolide antibiotic (e.g. azithromycin). Main finding - these treatments appear
Read more